PathScan: a tool for discerning mutational significance in groups of putative cancer genes
about
Current strategies for mutation detection in phenotype-driven screens utilising next generation sequencingIntegrated molecular analysis of clear-cell renal cell carcinoma.Computational characterisation of cancer molecular profiles derived using next generation sequencingWhole-genome analysis informs breast cancer response to aromatase inhibitionPersonalized pathway enrichment map of putative cancer genes from next generation sequencing dataMuSiC: identifying mutational significance in cancer genomes.Integrated analysis of germline and somatic variants in ovarian cancer.A novel network regularized matrix decomposition method to detect mutated cancer genes in tumour samples with inter-patient heterogeneity.Impact of mutations in Toll-like receptor pathway genes on esophageal carcinogenesis.Identification of collaborative driver pathways in breast cancer.Expanding the computational toolbox for mining cancer genomes.Simultaneous identification of multiple driver pathways in cancerComputational methods and resources for the interpretation of genomic variants in cancerKRAS and CREBBP mutations: a relapse-linked malicious liaison in childhood high hyperdiploid acute lymphoblastic leukemia.Background mutations in parental cells account for most of the genetic heterogeneity of induced pluripotent stem cells.Profiling of somatic mutations in acute myeloid leukemia with FLT3-ITD at diagnosis and relapse.Genomic landscape of liposarcoma.Genomic landscape of non-small cell lung cancer in smokers and never-smokers.DrGaP: a powerful tool for identifying driver genes and pathways in cancer sequencing studies.Identifying driver mutations in sequenced cancer genomes: computational approaches to enable precision medicine.Advances for studying clonal evolution in cancer.Genomic tools in acute myeloid leukemia: From the bench to the bedsideDeciphering oncogenic drivers: from single genes to integrated pathways.A simple consensus approach improves somatic mutation prediction accuracy.Computational Methods for Characterizing Cancer Mutational Heterogeneity.Computational approaches for the identification of cancer genes and pathwaysWhole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway.A weighted exact test for mutually exclusive mutations in cancer.Systematic analysis of somatic mutations driving cancer: uncovering functional protein regions in disease development.QuaDMutEx: quadratic driver mutation explorerN-myc downstream-regulated gene 1 promotes apoptosis in colorectal cancer via up-regulating death receptor 4.A mutational signature associated with alcohol consumption and prognostically significantly mutated driver genes in esophageal squamous cell carcinoma.Network-Based Coverage of Mutational Profiles Reveals Cancer Genes.The cJUN NH2-terminal kinase (JNK) signaling pathway promotes genome stability and prevents tumor initiation.Whole-exome sequencing reveals the origin and evolution of hepato-cholangiocarcinoma.Pathway-based dissection of the genomic heterogeneity of cancer hallmarks' acquisition with SLAPenrich.Identification of Biomarkers Based on Differentially Expressed Genes in Papillary Thyroid Carcinoma.
P2860
Q26785773-1B8BA80F-3A62-455A-802F-203306B5BA1EQ27852382-2130BFD6-649E-492B-85C4-5D899C6CE08CQ28080523-25F2182D-A137-42D7-8FA8-E8D70B74D795Q28269291-C8FDC6F8-1D80-4682-A58E-1FFFF8F733B1Q28729875-FF0A51AE-C9EF-4A69-8B5E-26E8FEABD18AQ30418806-F9507955-0496-4F73-9BAE-3C509FA8D23BQ33630954-C2F5E730-2BE4-4392-8D6F-77C6EDE03A57Q33767347-8C02E52C-76BE-4532-A78F-03492646AE5BQ33769334-4671579F-848B-4A27-A385-00E79D7A02DDQ33953601-4DE6D57F-CA10-4626-9A80-843F1C33E651Q34207474-2957C137-A1D6-4C07-8BF8-EC0BE7B42E68Q34743718-CD930875-423E-4CED-805E-C05AB7FBE3F1Q35674603-DE90B877-0B9F-4215-ABAE-0CE848388E72Q35932148-8E6DC5FD-1744-4C24-B0BC-EB3DC74E435FQ35947171-60A9DC72-FFE1-4E11-A3F8-8D194FF17C26Q36322776-5FB4BDFA-1497-43BA-994F-A4C56AE90DC5Q36618882-BB6B955A-45A4-408B-B166-FAFD840F4C87Q36851245-7B0FDE33-9F2A-4C75-A855-F91A1D463C9DQ37162578-A5ED0C22-13C3-4C9B-8BE9-1AEA61C1EA74Q37689928-5A0170D2-816D-444D-A4DC-0211F74A6F77Q38077016-5FBB83E8-D46A-4A68-B5B6-FEBCF6865B55Q38182932-F7E72B27-C91B-4EE2-8060-03BF4303F1FFQ38265995-BA4780D9-ED08-4837-AA3E-77DD18F21EE8Q38644089-36029800-5411-48B9-A39A-4F6ACE861D68Q38703541-FA6B5DD6-EA67-443D-B2B9-EFC7EFB8E23EQ38793593-DD019A39-365B-4AB3-A70B-62E454E6C563Q38977752-15D7E0A3-E775-4047-B766-6968F4050095Q39429299-05C41C78-2B23-4F11-80E5-F337B651E843Q39790685-A2C4ECC0-CFD0-439C-B657-933E15B15E1EQ42634268-892CA49A-ECE2-4215-8185-4CF8B7DCEBBFQ47108019-7BAF9A0B-C22D-407A-A17C-37DAF3F1FD6BQ47558765-14660229-FCE5-4A76-91C3-7C90C98F788FQ47731072-72497151-B63F-49C9-807B-9F26214D4BA0Q54977412-B03050A5-9502-4E7D-AA15-0C31B87B137AQ54985330-34F2B811-A1E0-4A4D-9138-9444A2348B44Q55080794-50213270-686E-4343-B2B7-D8B655107EE8Q55472371-C00D606C-2EF6-47BF-ACE4-B5974B65EF87
P2860
PathScan: a tool for discerning mutational significance in groups of putative cancer genes
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
PathScan: a tool for discernin ...... roups of putative cancer genes
@ast
PathScan: a tool for discernin ...... roups of putative cancer genes
@en
type
label
PathScan: a tool for discernin ...... roups of putative cancer genes
@ast
PathScan: a tool for discernin ...... roups of putative cancer genes
@en
prefLabel
PathScan: a tool for discernin ...... roups of putative cancer genes
@ast
PathScan: a tool for discernin ...... roups of putative cancer genes
@en
P2093
P2860
P356
P1433
P1476
PathScan: a tool for discernin ...... roups of putative cancer genes
@en
P2093
Elaine R Mardis
John W Wallis
Michael C Wendl
Richard K Wilson
P2860
P304
P356
10.1093/BIOINFORMATICS/BTR193
P407
P577
2011-04-14T00:00:00Z